Involvement of Annexin A2 in Serum-MAF Dependent Phagocytic Activation of Macrophages

Kumpei Kawakatsu1, Misato Maemura1, Yoshika Seta1

  • 1Frontiers of Innovative Research in Science and Technology (FIRST), Konan University, Kobe, Japan.

Anticancer Research
|July 20, 2021
PubMed
Abstract

Insights

Serum-derived macrophage activating factor (serum-MAF) rapidly activates phagocytosis via annexin A2 and calcium ions. This process involves annexin A2 translocation and F-actin accumulation, crucial for macrophage function.

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Serum-derived macrophage activating factor (serum-MAF) is known to induce rapid phagocytic activation.
  • This activation is dependent on F-actin accumulation within 5 minutes of serum-MAF addition.
  • Annexin A2, a calcium-binding protein, is implicated in cytoskeletal dynamics.

Purpose of the Study:

  • To investigate the role of annexin A2 in serum-MAF-mediated signaling.
  • To elucidate the mechanism of rapid phagocytic activation in macrophages.

Main Methods:

  • Immunostaining and confocal microscopy were used to analyze annexin A2 and F-actin localization.
  • Calcium (Ca2+) chelation with EGTA was employed to assess the role of calcium in the signaling pathway.

Main Results:

  • Annexin A2 translocated from the cytosol to the cell cortex within 30 seconds of serum-MAF stimulation.
  • Calcium chelation inhibited annexin A2 translocation, frill-like structure formation, and subsequent phagocytic activation.
  • These findings highlight the critical involvement of annexin A2 and calcium in the early stages of serum-MAF signaling.

Conclusions:

  • Annexin A2 and calcium ions are essential for the rapid phagocytic activation induced by serum-MAF.
  • Understanding this pathway provides insights into macrophage activation mechanisms.
  • This knowledge may contribute to the development of novel cancer immunotherapies.